Why the study?
Does intravascular platelet aggregation induced by collagen infusion cause microvascular injury in cats?
Does intravascular platelet aggregation induced by collagen infusion cause microvascular injury in cats?
Intravascular platelet aggregation induces microvascular injury and increases permeability, processes that are partly dependent on complement and neutrophils and can be inhibited by indomethacin.
Answers are grounded in this paper and cite their sources.
May link platelet aggregation to microvascular injury in models; leaves open human translation and therapeutic targeting.
Microvascular injury due to platelet aggregation was studied in cats for an hour after 1-hour intraaortic infusion of a suspension of collagen fibrils. Haematocrit and numbers of circulating platelets and leukocytes were repeatedly measured in arterial blood and a major cutaneous lymph vessel in the thigh was cannulated for measurement of lymph flow and erythrocyte counts in peripheral lymph. There were seven groups, each of eight cats, viz. normal cats infused with collagen (I) or vehicle (II) and collagen-infused cats which were platelet-depleted--by antiserum (III), or neutrophil-depleted--by anti-serum (IV), or decomplemented--by cobra venom (V), or pretreated with indomethacin--10 mg/kg (VI), or treated with nonimmunized serum (VII). Induced intravascular platelet aggregation reduced the numbers of circulating platelets and leukocytes, and increased haematocrit, lymph flow and numbers of red cells in peripheral lymph. These effects were inhibited by platelet depletion and indomethacin and attenuated by decomplementation and neutrophil depletion. Platelet aggregation was thus shown to induce microvascular injury and increase microvascular permeability, which is partly dependent on complement and neutrophils.
No takes yet. Share an insight, caveat, or question.
Jarle Vaage (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: